Novartis AG (NVSN) — Cash Flow Quality Index
Novartis AG (NVSN) has a Cash Flow Quality Index of 1.16x as of March 2026. Operating cash flow of MX$3.68 Billion exceeds net income of MX$3.16 Billion, indicating high earnings quality where cash backs reported profits. Explore how well can Novartis AG service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Novartis AG Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Novartis AG across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Novartis AG generate cash.
Annual Cash Flow Quality Index for Novartis AG (2014–2025)
Year-by-year earnings quality comparison for Novartis AG.
| Year | Quality Index | Operating CF (MXN) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.37x | MX$19.14 Billion | MX$13.98 Billion | ▼ -7.2% |
| 2024 | 1.48x | MX$17.62 Billion | MX$11.94 Billion | ▲ +36.8% |
| 2023 | 1.08x | MX$16.02 Billion | MX$14.85 Billion | ▼ -47.3% |
| 2022 | 2.05x | MX$14.24 Billion | MX$6.96 Billion | ▲ +226.2% |
| 2021 | 0.63x | MX$15.07 Billion | MX$24.02 Billion | ▼ -62.9% |
| 2020 | 1.69x | MX$13.65 Billion | MX$8.07 Billion | ▲ +45.6% |
| 2019 | 1.16x | MX$13.62 Billion | MX$11.73 Billion | ▲ +2.6% |
| 2018 | 1.13x | MX$14.27 Billion | MX$12.61 Billion | ▼ -30.9% |
| 2017 | 1.64x | MX$12.62 Billion | MX$7.70 Billion | ▼ -4.2% |
| 2016 | 1.71x | MX$11.47 Billion | MX$6.71 Billion | ▲ +155.5% |
| 2015 | 0.67x | MX$11.90 Billion | MX$17.78 Billion | ▼ -50.8% |
| 2014 | 1.36x | MX$13.90 Billion | MX$10.21 Billion | — |